Sponsor or institution

Clinical trials and research at Federal Research Institute of Pediatric Hematology, Oncology and Immunology

• 13Clinical trials
• 1Country

Newest trials

All recruiting trials (13)

• Prophylactic extrahepatic biliary drainage to prevent bile leakage after liver resection in children

  In kids who need liver removal and are at high risk for bile leakage, this study tests whether adding a biliary drainage procedure during surgery can prevent leaks within 90 days.

  Recruiting Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07867522

• Chemoimmunotherapy with autologous NK‑cell therapy for children with refractory or relapsed high‑risk neuroblastoma and ganglioneuroblastoma

  This treatment will test whether adding a child's own expanded natural killer (NK) cells to chemoimmunotherapy helps children with refractory or relapsed high‑risk neuroblastoma or ganglioneuroblastoma respond better.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07375563

• Co‑infusing regulatory T cell–enriched donor lymphocytes with CD3‑depleted stem cell grafts to prevent GVHD after haploidentical transplant in children and young adults

  This trial will try adding donor regulatory T cells to a partially T‑cell depleted stem cell graft plus short immunosuppression in children and young adults getting a haploidentical transplant to see if it reduces graft‑versus‑host disease.

  Recruiting Phase 2/3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07366801

• Donor-derived NK-cell infusions to prevent leukemia relapse after stem cell transplant

  This trial tests donor-derived, mbIL21-expanded natural killer (NK) cell infusions given before and after matched-related or haploidentical stem cell transplants to try to prevent relapse in children and young adults (about 1–25 years) with chemorefractory or MRD-positive acute leukemia.

  Recruiting Phase 2 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07256210

• Therapy plan for children with Down syndrome and acute myeloid leukemia in Russia

  This trial will test a standardized four-course chemotherapy program for children (0–18) with AML and Down syndrome in Russia to try to improve survival and reduce treatment side effects.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07232134

• Preventing GVHD in children and young adults with blood cancers

  This study is testing a new treatment plan to see if it can help prevent graft-versus-host disease in children and young adults with blood cancers after they receive a transplant.

  Recruiting Phase 2/3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06756152

• Assessing surgical risk factors for laparoscopic surgery in abdominal neuroblastoma

  This study is trying to see how different factors affect the safety and success of laparoscopic surgery for children with abdominal neuroblastoma.

  Recruiting Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06296732

• Using PTCy and Ruxolitinib to prevent GVHD after stem cell transplants in children with immune disorders

  This study is testing if a new combination of medications can help prevent graft-versus-host disease in children with immune disorders who are getting stem cell transplants.

  Recruiting Phase 2 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06199427

• Low dose treosulfan treatment for Nijmegen Breakage Syndrome

  This study is testing a gentler treatment plan using low dose treosulfan for patients with Nijmegen Breakage Syndrome who are getting a stem cell transplant to see if it helps them have better outcomes with fewer side effects.

  Recruiting Phase 2 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06198842

• Induction chemotherapy combined with immunotherapy for high-risk neuroblastoma

  This study is testing a new treatment that combines chemotherapy with immunotherapy to see if it helps children and teens with high-risk neuroblastoma do better and live longer.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06071897

• Using Sirolimus to Treat Juvenile Nasopharyngeal Angiofibroma in Children and Adolescents

  This study is testing if sirolimus can safely shrink juvenile nasopharyngeal angiofibroma tumors in children and teenagers aged 7 to 18.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT05549167

• Treatment protocol for B-cell mature non-Hodgkin's lymphoma in children and adolescents

  This study is testing different treatment plans for children and teenagers with B-cell non-Hodgkin's lymphoma to see who needs stronger therapy and who can safely have gentler options.

  Recruiting Phase 4 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow, RF · NCT05518383

• Combined immuno-chemotherapy for infants with acute lymphoblastic leukemia

  This study is testing a new treatment approach for infants with acute lymphoblastic leukemia to see if customizing their therapy based on their specific risks and responses can improve their chances of recovery.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow, Samory-Mashela,1 · NCT05029531

Quick answers

How many clinical trials run by Federal Research Institute of Pediatric Hematology, Oncology and Immunology are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 2: 3, Phase 2/3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →